Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.40 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29176807 | 0.98 | TSHR (0.54) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL2928727 | 0.98 | TSHR (0.54) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL9720123 | 0.93 | ALDH1A1 (0.53) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL30764112 | 0.93 | ALDH1A1 (0.53) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL30764109 | 0.84 | KMT2A (0.49) | TSHRALDH1A1KMT2APTPN11CA2 | |
| SCHEMBL15698201 | 0.83 | HTR6 (0.50) | TSHRSMN1; SMN2ALDH1A1CASP6POLB | |
| SCHEMBL2172519 | 0.79 | ALDH1A1 (0.52) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL15862378 | 0.79 | ALDH1A1 (0.41) | TSHRSMN1; SMN2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL1502176 | 0.79 | KMT2A (0.62) | ALDH1A1TDP1CASP6POLBKMT2A | |
| Triphenylphosphine Oxide SCHEMBL8328973 | 0.78 | CA2 (0.52) | TSHRSMN1; SMN2ALDH1A1TDP1CASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231682-B1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-01-06 | — | — | EP | disclosed |
| US-8394978-B2 | Sulfonated organophosphine compounds and use thereof in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-03-12 | — | — | US | disclosed |
| US-20110054205-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2231682-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES | Dow Global Technologies Inc. (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009091671-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054205-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES | IP6K3, ALK, GRK1 | TSHR 1784/4885SMN1; SMN2 2989/4885ALDH1A1 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.